US FDA’s Anti-Misinformation Campaigns Look Safer After Supreme Court Oral Arguments

FDA’s efforts to tackle misinformation may face fewer legal obstacles moving forward, following oral arguments at the Supreme Court on a case that could have broad ramifications for how the government communicates public health information.